Christina Care Institutional Review Board

Newark, Delaware 19713

0 studies enrolling now · 2 studies all time

What they study most

Neoplasm Metastasis, Urothelial Carcinoma

Studies at this site

• A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies — Running, not enrolling
• Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma — Completed